Good Lifestyle

From the household essentials you need to grab on the way home from work to the groceries you need to cook dinner each week, Walmart is often a one-stop shop for many shoppers looking to capitalize on the retailer's low prices. But the company is also a popular destination for medication, competing with CVS and Walgreens as an affordable destination for your over-the-counter meds and prescriptions. If you get your prescriptions filled at Walmart, however, a new decision could limit your options. Read on to find out what Walmart is now banning completely.

Basahin ito sa susunod:Walmart Just Issued This Urgent Warning.

When the COVID pandemic forced us indoors, many people started taking advantage of telehealth services in order to access healthcare while still keeping themselves safe. According to the Kaiser Family Foundation (KFF), telehealth accounted for less than 1 percent of outpatient visits before the pandemic, but at its pandemic peak between March and Aug. 2020, it reached 13 percent. Since then, people have continued to rely on online health services for ease, with companies like Cerebral Inc. and Done Health taking off with offers of virtual diagnoses and treatments.

Basahin ito sa susunod:If You Get Prescriptions From CVS or Walgreens, Experts Have a New Warning.

But some telehealth patients might have trouble getting their medications now. On May 26, Walmart confirmed that it would stop filling certain prescriptions from Cerebral and Done, Reuters reported. According to the news outlet, the retailer will no longer allow prescriptions for controlled substances from either of the two telehealth startups. The Wall Street Journal reports that Walmart did not elaborate on why it made this decision, but said it comes following an "audit and compliance process."

"Walmart is committed to patient safety and well-being," a spokeswoman for the company told the newspaper. "We have an audit and compliance process in place that guides our decisions."

Walmart's decision follows significant concern over telehealth companies prescribing medication to treat attention-deficit hyperactivity disorder (ADHD). Ayon kayThe Wall Street Journal, Cerebral and Done treat tens of thousands of patients for ADHD between the two companies, and they often do so by prescribing stimulants such as Adderall.ae0fcc31ae342fd3a1346ebb1f342fcb

The U.S. Food and Drug Administration (FDA) classifies Adderall as a schedule II controlled substance due to its "high potential for abuse" as an amphetamine. While still permitted for medical use, the agency recommends treatments like Adderall be "prescribed or dispensed sparingly." As a result, in-person visits were once required for stimulant prescriptions, but this restriction was eased when COVID hit and doctors were permitted to prescribe these medications remotely.

The growth of companies like Cerebral and Done has coincided with an increase in demand for stimulants like Adderall. According to Iqvia Holdings Inc., a data and research-services provider for the pharmaceutical industry, Adderall prescriptions dispensed in the U.S. hit 41.4 million last year—a 10 percent increase from 2020. And in March 2022, several current and former employees of Cerebral and Done told The Wall Street Journal they felt pressured by the company to prescribe stimulants despite feeling like their video evaluations weren't sufficient enough to properly diagnose ADHD.

Kaugnay:Para sa higit pang napapanahon na impormasyon, mag-sign up para sa aming pang-araw-araw na newsletter.

Walmart is not alone in its recent decision. According to Reuters, CVS has also confirmed that it will no longer be accepting prescriptions for controlled substances issued by Cerebral and Done, starting May 26. A spokesperson for the drug store chain told the news outlet that this decision follows a review it conducted on the two telehealth companies and is the result of it being "unable to resolve concerns we have with Cerebral and Done Health."

Cerebral told The Wall Street Journal Na nadama nito ang desisyon ng CVS ay kapus -palad, idinagdag na ito ay "ginagawa ang lahat na posible upang matiyak na ang mga pasyente na ito ay makakuha ng access sa mga gamot na tinukoy ng kanilang mga nagbibigay ng pangangalaga sa kalusugan." Sinabi rin ng startup ng Telehealth na natutunan lamang nito ang desisyon ni Walmart mula sa ulat ng pahayagan at naabot nito ang tingi upang maunawaan ang higit pa tungkol sa desisyon nito at kung paano ito makakaapekto sa mga pasyente ng cerebral.

Ngunit sa Mayo 9, cerebralSinimulan ang pag -pause ng mga reseta ng mga kinokontrol na sangkap tulad ng Adderall at Ritalin bilang isang paggamot sa ADHD para sa mga bagong pasyente. Pagkatapos noong Mayo 17, inihayag ng kumpanya ng telehealth na ihinto nito ang reseta ng halos lahat ng mga kinokontrol na sangkap. Ang kwento ay maaaring hindi natapos, gayunpaman. Ang kumpanya ay ngayonsa ilalim ng pagsisiyasat Sa pamamagitan ng Kagawaran ng Hustisya ng Estados Unidos (DOJ) para sa mga gawi sa reseta nito, ayon sa The Verge.

Basahin ito sa susunod:Ito ang lahat ng mga lokasyon ng Walmart na nagsasara magpakailanman sa pagtatapos ng Mayo.